Retrovirus isolated from human lymphoma cell lines
    2.
    发明授权
    Retrovirus isolated from human lymphoma cell lines 失效
    从人类淋巴细胞细胞系分离的逆转录病毒

    公开(公告)号:US5108920A

    公开(公告)日:1992-04-28

    申请号:US361855

    申请日:1989-06-05

    IPC分类号: C07K14/15 C12N7/00 C12Q1/70

    摘要: A novel retrovirus isolated from human lymphoma cells is disclosed. The retrovirus is characterized by a C-type retroviral particle of approximately 100 nm diameter; and an approximately 27,000 molecular weight p24 core protein. Also disclosed are cell lines from which the virus can be obtained and screening methods for detecting the presence of the virus in human sera.

    摘要翻译: 公开了从人类淋巴瘤细胞分离的新型逆转录病毒。 逆转录病毒的特征在于直径约100nm的C型逆转录病毒颗粒; 和约27,000分子量的p24核心蛋白。 还公开了可以从其获得病毒的细胞系和用于检测人血清中病毒存在的筛选方法。

    Purified trichosanthin and method of preparation
    3.
    发明授权
    Purified trichosanthin and method of preparation 失效
    纯化的trichosanthin及其制备方法

    公开(公告)号:US5077390A

    公开(公告)日:1991-12-31

    申请号:US404328

    申请日:1989-09-07

    IPC分类号: A61K38/00 C07K14/415

    CPC分类号: C07K14/415 A61K38/00

    摘要: A substantially pure, hemagglutinin-free composition of trichosanthin, and a method of producing the composition is disclosed. A plant extract from Trichosanthes kirilowii is contacted with an anionic exchange resin to remove contaminating hemagglutinins, and trichosanthin is further purified from the extract by cation exchange chromatography to a purity of greater than 95%.

    摘要翻译: 公开了一种基本上纯的,不含血凝素的trichosanthin组合物及其制备方法。 将来自Trichosanthes kirilowi​​i的植物提取物与阴离子交换树脂接触以除去污染性血凝素,并且通过阳离子交换层析从提取物中进一步纯化trichosanthin,纯度大于95%。

    Recombinant trichosanthin and coding sequence
    5.
    发明授权
    Recombinant trichosanthin and coding sequence 失效
    重组trichosanthin和编码序列

    公开(公告)号:US5166056A

    公开(公告)日:1992-11-24

    申请号:US804293

    申请日:1991-12-09

    摘要: Disclosed are the entire coding sequence for unprocessed and mature trichosanthin from Trichosanthes kirilowii, and primers derived from this coding sequence for use in obtaining the coding sequences of ribosome inactivating proteins which have regions of amino acid sequence identical to those of trichosanthin. Also disclosed is a recombinant trichosanthin protein produced from the coding sequence, and the mature protein with amino-terminal and/or carboxy-terminal extensions.

    摘要翻译: 公开了来自Trichosanthes kirilowi​​i的未加工和成熟的trichosanthin的整个编码序列,以及用于获得具有与trichosanthin的氨基酸序列相同的氨基酸序列的核糖体灭活蛋白的编码序列的该编码序列的引物。 还公开了由编码序列产生的重组trichosanthin蛋白质和具有氨基末端和/或羧基末端延伸的成熟蛋白质。

    Recombinant trichosanthin and coding sequence
    6.
    发明授权
    Recombinant trichosanthin and coding sequence 失效
    重组trichosanthin和编码序列

    公开(公告)号:US5128460A

    公开(公告)日:1992-07-07

    申请号:US504775

    申请日:1990-04-04

    摘要: Disclosed are the entire protein and nucleic acid coding sequences for unprocessed and mature trichosanthin protein from Trichosanthes kirilowii. A recombinant trichosanthin protein produced from the coding sequence, and the trichosanthin protein with amino-terminal and/or carboxy-terminal extensions are also described. Primers derived from the coding sequence are disclosed for use in obtaining the coding sequences of ribosome-inactivating-proteins which have regions of amino acid sequence identical to those of trichosanthin. Further, a multigene family of ribosome-inactivating-protein encoding genes of Trichosanthes kirilowii is also described.

    摘要翻译: 公开了来自Trichosanthes kirilowi​​i的未加工和成熟的trichosanthin蛋白的整个蛋白质和核酸编码序列。 还描述了由编码序列产生的重组trichosanthin蛋白质和具有氨基末端和/或羧基末端延伸的trichosanthin蛋白质。 公开了从编码序列衍生的引物用于获得具有与天花黄素相同的氨基酸序列区域的核糖体失活蛋白的编码序列。 此外,还描述了Trichosanthes kirilowi​​i的核糖体灭活 - 蛋白质编码基因的多基因家族。

    Method of selectively inhibiting HIV
    7.
    发明授权
    Method of selectively inhibiting HIV 失效
    选择性抑制艾滋病毒的方法

    公开(公告)号:US4869903A

    公开(公告)日:1989-09-26

    申请号:US179274

    申请日:1988-04-08

    摘要: A method of inhibiting HIV replication in and cellular proliferation of HIV-infected cells. The infected cells are exposed to a single-chain ribosome inactivating protein, at a protein concentration and for an exposure period sufficient to produce a substantial reduction in (a) the level of HIV antigen or reverse transcriptase associated with the infected cells, (b) the ratio of viability of infected/uninfected T cells, and/or (c) the ratio of HIV antigen/cellular antigen in infected macrophages. The method is used to treat HIV infection in humans.

    摘要翻译: 抑制艾滋病病毒感染细胞的HIV复制和细胞增殖的方法。 (a)与感染细胞相关的HIV抗原或逆转录酶水平的显着降低;(b)在感染细胞中,感染的细胞暴露于单链核糖体灭活蛋白,蛋白质浓度和暴露时间足以产生(a) 感染/未感染的T细胞的存活率和/或(c)感染的巨噬细胞中HIV抗原/细胞抗原的比例。 该方法用于治疗人类的HIV感染。